W 2 Professorship in T-cell therapy

W 2 Professorship in T-cell therapy

Universität Regensburg

Regensburg, Germany

Universität Regensburg, Germany
The Faculty of Medicine invites applications for a

W 2 Professorship in T-cell therapy

offered as a civil servant position with limited tenure

and commencing as soon as possible. The appointment will be for six years. A civil servant position with limited tenure may be converted into a permanent position after a minimum of three years. If the applicant is already a member of the university at the time of appointment, the conversion to a permanent position is only permitted in exceptional cases (see BayHSchPG Art. 8, (2), Sentence 5).

The successful candidate is expected to represent his specialty in teaching and research. The professorship is at the center of the faculty’s focus on immunotherapy, tumor research and transplantation medicine. It is assigned to the chair of Genetic Immunotherapy and thus to the “Regensburg Center for Interventional Immunology (RCI)”, which is to be transferred to a non-university research institution on July 1st, 2019. The RCI has the infrastructure for manufacturing human cell therapy products for clinical applications at the José Carreras Center for Somatic Cell Therapy (JCC).

One of the main targets of the RCI is the development and application of modern immune cell therapy methods in oncology as well as autoimmune and transplantation medicine. The key tasks of the professorship include the preclinical and clinical development of innovative approaches to the functional optimization of T-lymphocytes through genetic manipulation of the antigen receptor (TCR, CAR) and of associated signal complexes, as well as the implementation of molecular genetic switches to control the activity of manipulated T-cells.

The JCC and the close connection to the University Hospital Regensburg offer excellent possibilities of planning and executing early clinical studies with gene-therapeutically modified cells. Therefore, we are looking for a personality with relevant experience and an excellent scientific profile with corresponding third-party funding, who works in the field of gene immunotherapy with translational goals, originality and international visibility. This is why experience in the development and implementation of clinical trial protocols is necessary.

Required qualifications for applicants include a university degree preferably in Medicine, a PhD degree, pedagogical aptitude and additional scientific merits (habilitation, junior professorship or equivalent scientific credentials, possibly from outside of academia).

As we are seeking to increase the number of female faculty members, women are strongly encouraged to apply. In addition, Universität Regensburg supports work-family balance (for further information, visit
http://www.uni-regensburg.de/equal-opportunities/index.html).

The civil service requirements for an appointment are governed by the provisions of the BayBG and the BayHSchPG. The age limit of Art. 10 (3) BayHSchPG must be observed.

Universität Regensburg is an equal opportunity employer and candidates with disabilities will be given preference, provided they are equally qualified.

This is the English translation of a German job advertisement published by the Universität Regensburg at www.uni-regensburg.de/universitaet/stellenausschreibungen/.
Only the original German text is legally binding.

Applications including a statement of interest, curriculum vitae, list of publications, teaching experience and visions/outlines/plans/sketches for future research should be sent to the Dean of the Faculty of Medicine, University Regensburg, Germany (in paper and on USB-stick) until the 15th of March 2019 together with the short application form for professorships http://www.uni- regensburg.de/Fakultaeten/Medizin/index.html

Please apply via recruiter’s website.

Favorite